SUMMARY A prospective study in South-East England during 15 months in 1983-1984 recruited 100 patients with acute idiopathic neuropathy. After 12 months 67% had recovered completely, 20% were still significantly disabled and 13% had died. Ten of the 13 deaths were attributable to the neuropathy. The major features in the initial assessment which were associated with persistent disability were the time taken to become bedbound, requirement for ventilation, age greater than 40 years, and small or absent compound abductor pollicis brevis muscle action potentials elicited by stimulation of the median nerve at the wrist. These four variables have been combined in a statistical model to predict outcome for individual patients with acute idiopathic neuropathy.
Although the majority of patients with Guillain-Barre syndrome make an acceptable functional recovery, a proportion succumb to the acute illness while others retain significant residual disability.' It is difficult to estimate how many patients remain disabled from the literature. No large scale prospective study has ever been carried out and the available retrospective studies give an incomplete picture of outcome. Data have been collected prospectively on 100 patients who were thought on presentation to have Guillain-Barre syndrome and the group followed for 12 months. Clinical and laboratory features at presentation are analysed for their value in predicting outcome.
Patients and methods

Clinical studs Neurologists within the four Thames
Regional Health Authorities were notified of our prospective study of acute idiopathic neuropathy and permission sought to survey patients. Ethical approval was obtained from the National Hospitals for Nervous Diseases and Guy's Hospital. The Lancet and the British Medical Journal published short letters requesting permission to survey patients in district general hospitals under the care of general physicians alone.
All the eligible patients who came to our notice from September 1983 until December 1984 were admitted to the study. Ninety-one patients came from hospitals within the four Thames Health Regions, six from Wessex, two from East Anglia and one from Trent Health Region. The population of the Thames Health Regions is about 13 7 million.
New patients were visited in their local hospitals where one of us (JBW) reviewed their clinical records and interviewed and examined the patients. Patients were included in the study if they fulfilled inclusion criteria (table 1) which were designed to correspond at the time of notification to a diagnosis of acute Guillain-Barre syndrome. Since the purpose of the study was to assess prognostic factors, all patients were retained in the study even if they subsequently proved to have an atypical, relapsing or progressive course.
Standardised data sheets were employed for transfer of information to computer and to ensure uniformity. Patients were questioned about the mode of presentation of the neuropathy and particular attention paid to the dates of onset of neuropathic signs and the tempo of the ensuing functional disability. Patients were graded using a functional scale (table 2) .
A standardised examination involved grading of strength according to the Medical Research Council Scale (0-5). An assessment of autonomic function was made and, where possible, measurements of nerve conduction performed. Blood was taken for immunological tests which will be reported separately. A prospective study of acute idiopathic neuropathy. L Clinicalfeatures and their prognostic value Limb weakness was detected in all patients and both distal and proximal muscles were usually involved. Upper limbs were never affected alone although weakness was occasionally more severe in the arms than the legs. Wasting without other identified cause was present at the time of the first assessment in 32 patients, of whom 12 had symptoms for less than 2 weeks and six for less than one week. Forty-eight patients eventually developed wasting in the upper limbs and 51 in the lower limbs.
All tendon reflexes were lost in 83% of the patients at sonic-stage in the illness and 54% had two or more absent abdominal reflexes. Two patients were included in the study who retained all reflexes, but had neurophysiological evidence of demyelinating neuropathy. Five patients had at least one unequivocal extensor plantar response. In one patient this was eiplained by coincidental Friedreich's ataxia and in another severe papilloedema was also present. In the remaining three cases no other signs of central nervous system involvement were noted. All three had sufficient voluntary flexion of the toes to enable a flexor response to be made and re-examination in the convalescent phase revealed normal plantar responses. Two patients were considered to have limb incoordination out of proportion to their level of weakness or loss ofjoint position sense. Loss of sensation on examination was less common than symptoms of a sensory disturbance. Loss of modalities mediated by large fibres was more common than impairment of pin prick (table 3) .
Twelve per cent of patients were still capable of walking unaided at peak disability, 7% required support, 47% were chair or bed bound. 23% of patients required ventilation at maximum deficit and went on to improve. A further 10% required ventilation but eventually died and 3% died without ever receiving assisted ventilation. Cerebrospinal fluid The cerebrospinal fluid (CSF) protein concentration (mean 1-2 g/l range 0-1-60) was increased (> 0 4 g/l) in 80% of the 92 patients in whom the examination was performed. Abnormal values were more common when the sample was collected after the first week of the illness. CSF cell counts were high (> 5 cells/pl) in 11 of patients. The -median count for these patients was 8/pl, range 6 to 103/p1. The timing of CSF examination in this group was the same as in patients in whom normal cell counts were found. Clinical course Follow-up examinations showed the expected improvement in the majority of patients but 13 patients died and 19 were still disabled at the end of one year (fig). One patient with residual disability due to Friedreich's ataxia and three who emigrated were excluded from this analysis. The most common cause of death was cardiac arrest (table 4 Clinical features and outcome Poor outcome was defined in two ways, prolonged disability confining the patient to bed (disability grade 4 or greater after 3 months) or inability to perform manual work after 12 months (disability grade 2 or greater). The main features associated with still being bed-bound at 3 months were requirement for ventilation, rapid development of inability to walk and evidence of inflammation fromn the peripheral blood white cell count and sedimentation rate (table 5) . The main features associated with inability to undertake manual work after one year also included a requirement for ventilation and a rapid onset of inability to walk but the inflammatory features in the peripheral blood at onset were not significantly associated with poor outcome according to this criterion (table 6) . No significant correlation was seen with sensory deficit (pin prick, light touch, joint position sense or vibration sense), incontinence, facial weakness, sex, or CSF findings (protein or cell count).
Correlation between electrophysiological features and outcome There was a significant association between poor outcome and small amplitude of the action potential evoked in abductor pollicis brevis by stimulation of the median nerve at the wrist (table 7) . Slowed motor conduction in the forearm segment of the median nerve was also more common in patients with a poor outcome whereas the other electrophysiological measurements were not valuable in predicting outcome. Abnormal F wave latencies were the most common electrophysiological abnormality occurring in 90% of lower limb examinations but provided only poor discrimination between patients destined to have a poor or good outcome at either 3 or 12 months. Prediction ofoutcome Our analysis of predictive factors was focused on outcome at 12 months since such persistent disability usually has a more profound overall effect on a patient than severe deficit after 3 months which eventually resolves completely. The patient with Friedreich's ataxia was excluded because his disability was not due to Guillain-Barre syndrome. Three patients who had achieved a good outcome by Unfortunately the number of patients with a poor prognosis is small in any individual study which makes it difficult to define any characteristics that might separate these patients from the majority. Osler and Sidell7 suggested that patients with a strictly motor neuropathy and no sphincter disturbance were more likely to have a benign prognosis and described 10 cases which followed that pattern. They recommended strict adherence to the diagnostic features of Guillain, Barre and Strohl's original cases. Marshall8 described 35 patients including some with severe sensory loss or sphincter disturbance and could find no evidence that such features influenced outcome adversely. A particularly severe motor deficit appears to carry a geater risk of residual disability according to a number of authors.9"1 Two paediatric studies have suggested that the time taken to improve also has prognostic value.'2 13 Eberle and colleagues'2 examined the case records of 47 children referred to a rehabilitation unit for factors that might correlate with the degree of eventual recovery. They concluded that an interval of greater than 18 days from maximum deficit to onset of improvement was associated 610 with incomplete recovery in a large number of patients. Other factors more common in the poor outcome group were absence of tendon reflexes from onset, severe weakness in the distal muscles and curiously a relatively low CSF protein. This latter feature may be an artifact, since the majority of studies '4 16 have failed to find any correlation between CSF protein and outcome. Normal or relatively low CSF protein measurements are not unusual in the first week of the illness 7 and it is possible that more severe cases are admitted and have a lumbar puncture sooner. Although Osler and Sidell7 considered that a CSF pleocytosis predicted a relatively poor outcome, we and most other authors did not find that the presence of cells in the CSF was a significant prognostic factor.8 14 16 In this study outcome at both 3 and 12 months was strongly influenced by the severity of peak deficit and its speed of progression. Patients who became tetraplegic rapidly had a significantly greater chance of lasting disability. This may reflect the severity ofthe inflammatory response in the nerves, which if more severe would be likely to cause intraneural oedema, raised endoneurial pressure and axonal damage. In accord with this idea two indices of systemic inflammation, peripheral blood white cell count and sedimentation rate, were more often abnormal in those patients with poor outcome at 3 months.
Ropper"9 has recently drawn attention to a subgroup of patients with hyperacute Guillain-Barre syndrome who have a poor outcome.
The best measure of the speed of progression of the disease appeared to be the duration of the neuropathy before walking became impossible. This interval was easier to measure than the time taken to reach peak deficit, which can only be determined after the peak deficit has occurred and is often uncertain. The 32 patients in the poor outcome group at 12 months, are largely accounted for by the 28 who reached grade 4 within 7 days. Three others relapsed or developed chronic progressive neuropathy. Only one patient with a true monophasic disease and poor outcome would not have been identified by this measure of outcome alone.
The latency from onset of neuropathy until improvement began was not useful in predicting outcome. This conclusion conflicts with previous observations in which patients taking longer than 3 weeks to improve had significantly more residual sequelae. 20 The onset of improvement is difficult to measure accurately since minor fluctuations in neurological examination may be caused by intercurrent infections or disturbances of mood and not followed by sustained improvement. The duration of the plateau phase, which is subject to the same difficulties The electrophysiological abnormalities found in our patients were similar to those previously reported.'8 21 22 Of our patients 56% had slowed upper limb, and 68% slowed lower limb motor nerve conduction. Proximal conduction was more commonly affected as indicated by abnormalities in F wave conduction at the wrist in 83%. Many patients had significant reductions in the amplitude of sensory action potentials and slowing of sensory conduction, especially later in their illness. Only two electrophysiological features appeared to have an important bearing on outcome. These were the compound muscle action potential of abductor pollicis brevis evoked by stimulation of the median nerve at the wrist and a markedly slowed upper limb conduction velocity. A grossly reduced or absent compound muscle action potential in abductor pollicis brevis alone would identify about one third of the patients with a poor outcome after 12 months. The measurements of muscle action potentials were obtained with conventional bipolar surface electrodes used routinely for conduction studies. Although every attempt was made to achieve the optimum electrode position this method is less reliable than the use of a single electrode placed over the muscle belly with a reference electrode placed over the tendon. This could not havebeen a disadvantage when no evoked potential was seen. It was this abnormality which had the greatest prognostic importance.
If an evoked muscle action potential is absent it is not possible to be certain whether demyelination with complete conduction block or axonal degeneration is responsible. Where muscle action potentials could be recorded but were very small (> I mV), dispersion of the potential indicated that conduction block was at least partly responsible for the reduced amplitude. However, the presence of wasting shows that axonal A prospective study of acute idiopathic neuropathy. I. Clinicalfeatures and their prognostic value degeneration was an important pathological feature in the poor outcome patients. The pathology of a recent case of acute axonal neuropathy has been described24 and there is evidence of a correlation between very small distally recorded compound muscle action potentials and the subsequent development of fibrillation. 23 Spontaneous fibrillation was associated with poor outcome in a number of previous studies.'5 16 21 In one of these studies2' 13 of 19 patients with spontaneous fibrillation showed no signs-of recovery after 2 months in hospital and 17 had muscle atrophy. Only limited sampling of muscles was performed in most of our patients and examinations were usually performed within the first 3 weeks, before fibrillation has usually appeared. 22 A weak but significant association existed between the median nerve motor conduction velocity in the acute stage and eventual outcome. Abnormalities in lower limb conduction did not appear to have any prognostic value. A few studies have found conduction measurements to be of some value in predicting outcome' 525 26 but others have found no consistent correlation.2' 27 This present study indicates a low relative risk attributable to slowed upper limb conduction so that a small study with relatively few poor outcome patients would be likely to miss an effect of this magnitude.
We managed to recruit 86 of our 100 patients from within the Thames Regions among a population of 13-7 million. We have attempted to recruit as many patients with Guillain-Barre syndrome as possible from a given study area so that any bias from patterns of referral might be reduced. If we assume an incidence of Guillain-Barre syndrome of no more than 19 cases per 100,00 population28 then we might have expected a maximum of 264 cases. This suggests a case ascertainment of at least 33%. We recognise that this ascertainment is incomplete but the outcome of this study group is more likely to be representative of the prognosis of Guillain-Barre syndrome patients in general than a study based on the experience of a single institution.
Ten patients who died during the first 12 weeks of the illness have been included in the modelling analysis. It is possible that features influencing death (such as autonomic disturbance) might be different from those influencing residual disability so that some of the patients that died might have been destined to make a good recovery. This seems very unlikely for the three patients that died late in the course of their illness since they retained significant residual disability up to the time of death. In order to exclude any bias introduced by excluding these 10 patients we repeated the analysis with the early deaths removed. No significant difference in the results was obtained and the same four features emerged as having major prognostic importance, although the adverse effect of requiring ventilation was reduced.
A statistical model was constructed from the variables of predictive value (table 8) which was derived from the 82 patients who became bedbound. The validity of this model will have to be tested on a fresh population of patients with acute idiopathic neuropathy. The accuracy of prediction derived from one set of data would be expected to be less good when applied to new sets of data, particularly when a large number of variables have been used to calculate predicted probabilities since the results become tailored to the data from whence they were derived. Relatively few variables were used to create our model in order to reduce such errors.
